Merck KGaA subsidiary EMD Serono and Pfizer (PFE -0.8%) announce FDA approval for Rebi Rebidose,...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Merck KGaA subsidiary EMD Serono and Pfizer (PFE -0.8%) announce FDA approval for Rebi Rebidose, a single-use auto-injector for the self-administration of Rebif, a treatment multiple sclerosis. PFE says the drug will be available with three different delivery options in the U.S. early this year.